32 related articles for article (PubMed ID: 3778487)
1. Cirsiliol regulates mitophagy in colon cancer cells via STAT3 signaling.
Jiang T; Peng L; Wang Q; Huang B; Peng D; Men L; Jiang Y; Zhu M; Wang M; Lin L; Lv J; Li S
Cancer Cell Int; 2022 Oct; 22(1):304. PubMed ID: 36207761
[TBL] [Abstract][Full Text] [Related]
2. Knock-out of 5-lipoxygenase in overexpressing tumor cells-consequences on gene expression and cellular function.
Weisser H; Göbel T; Melissa Krishnathas G; Kreiß M; Angioni C; Sürün D; Thomas D; Schmid T; Häfner AK; Kahnt AS
Cancer Gene Ther; 2023 Jan; 30(1):108-123. PubMed ID: 36114329
[TBL] [Abstract][Full Text] [Related]
3.
Jaroš P; Vrublevskaya M; Lokočová K; Michailidu J; Kolouchová I; Demnerová K
Microorganisms; 2022 Jan; 10(1):. PubMed ID: 35056620
[TBL] [Abstract][Full Text] [Related]
4.
Vahabi S; Hakemi-Vala M; Gholami S
Adv Biomed Res; 2019; 8():22. PubMed ID: 31016180
[TBL] [Abstract][Full Text] [Related]
5. Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway.
Prasad P; Vasas A; Hohmann J; Bishayee A; Sinha D
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30708951
[TBL] [Abstract][Full Text] [Related]
6. Medicinal plants with potential anti-arthritic activity.
Choudhary M; Kumar V; Malhotra H; Singh S
J Intercult Ethnopharmacol; 2015; 4(2):147-79. PubMed ID: 26401403
[TBL] [Abstract][Full Text] [Related]
7. Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation.
Woessner DW; Lim CS
Mol Pharm; 2013 Jan; 10(1):270-7. PubMed ID: 23211037
[TBL] [Abstract][Full Text] [Related]
8. 5-lipoxygenase: underappreciated role of a pro-inflammatory enzyme in tumorigenesis.
Steinhilber D; Fischer AS; Metzner J; Steinbrink SD; Roos J; Ruthardt M; Maier TJ
Front Pharmacol; 2010; 1():143. PubMed ID: 21833182
[TBL] [Abstract][Full Text] [Related]
9. Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer.
Barry M; Cahill RA; Roche-Nagle G; Neilan TG; Treumann A; Harmey JH; Bouchier-Hayes DJ
Ir J Med Sci; 2009 Jun; 178(2):201-8. PubMed ID: 19340516
[TBL] [Abstract][Full Text] [Related]
10. Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines.
Desplat V; Dulery C; Praloran V; Denizot Y
Mediators Inflamm; 1999; 8(2):115-8. PubMed ID: 10704149
[TBL] [Abstract][Full Text] [Related]
11. Syntheses of 5,6,7- and 5,7,8-trioxygenated 3',4'-dihydroxyflavones having alkoxy groups and their inhibitory activities against arachidonate 5-lipoxygenase.
Horie T; Tsukayama M; Kourai H; Yokoyama C; Furukawa M; Yoshimoto T; Yamamoto S; Watanabe-Kohno S; Ohata K
J Med Chem; 1986 Nov; 29(11):2256-62. PubMed ID: 3783588
[TBL] [Abstract][Full Text] [Related]
12. 5-Lipoxygenase: a rational target for therapy of inflammatory bowel disease?
Wallace JL
Trends Pharmacol Sci; 1990 Feb; 11(2):51-3. PubMed ID: 2180156
[No Abstract] [Full Text] [Related]
13. The use of leukotriene D4 receptor antagonists and 5-lipoxygenase inhibitors to define a role for leukotrienes in allergic reactions.
Ford-Hutchinson AW
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():507-10. PubMed ID: 2546393
[No Abstract] [Full Text] [Related]
14. Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines.
Tsukada T; Nakashima K; Shirakawa S
Biochem Biophys Res Commun; 1986 Nov; 140(3):832-6. PubMed ID: 3778487
[TBL] [Abstract][Full Text] [Related]
15. Potent and selective 5-lipoxygenase inhibitors: cirsiliol and AA-861.
Kohno SW; Ohata K; Maki Y; Horie T; Yoshimoto T; Yamamoto S
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():217-9. PubMed ID: 2936097
[No Abstract] [Full Text] [Related]
16. Arachidonate 5-lipoxygenase and its new inhibitors.
Yamamoto S; Yoshimoto T; Furukawa M; Horie T; Watanabe-Kohno S
J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):349-52. PubMed ID: 6432877
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
